BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Nomura maintains buy on Dr Reddy's Laboratories
The warning letter for the formulation plant is a negative surprise. The revenue contribution from the injectable facility is very limited at this stage. While the warning letter delays new approvals for products linked to these facilities, the production and sales of approved products can continue.